IRWD EBITDA Growth
Ironwood Pharma Inc Class A · EBITDA Growth
IRWD EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported148.68%period ending
IRWD TTM EBITDA YoY % (-16.86% → 148.68%)
Year-over-year change
High-resolution chart · PNG
IRWD ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 148.6809% | |
| 167.3659% | |
| 22.906% | |
| 37.7397% | |
| -20.0342% | |
| -48.7188% | |
| -51.8747% | |
| -55.6321% | |
| -54.9328% | |
| -44.0376% | |
| -20.9086% | |
| -0.6189% | |
| 14.5869% | |
| 10.4577% | |
| 13.0049% | |
| 5.0216% | |
| 10.3101% | |
| 34.6748% | |
| 58.1876% | |
| 55.0047% | |
| 59.4746% | |
| 47.1875% | |
| 45.0557% | |
| 268.3741% | |
| 185.8439% | |
| 165.0918% | |
| 148.837% | |
| 123.0164% | |
| -381.1303% | |
| -248.3933% | |
| -213.0402% | |
| -80.8369% | |
| 66.0313% | |
| 23.3469% | |
| -110.7365% | |
| -223.7072% | |
| -105.2787% | |
| 8.0793% | |
| 69.2324% | |
| 76.7864% | |
| 63.6458% | |
| 45.2401% | |
| 35.1971% | |
| 24.2941% | |
| 32.7955% | |
| 27.8522% | |
| 34.6361% | |
| 28.2988% | |
| -42.5857% | |
| -70.7349% | |
| -291.7117% | |
| -870.0776% | |
| -41.3736% | |
| -57.8563% | |
| -9.5361% | |
| 60.7482% | |
| -63.5866% | |
| -25.963% | |
| -3.0017% | |
| 6.691% | |
| 3.1812% | |
| 5.6392% | |
| 16.5169% | |
| -16.8557% |